RAXTOZINAMERAN

UNII:	N36VHK46PR
Formula:
Preferred Substance Name:	RAXTOZINAMERAN

2887554-49-4
BNT162B2 OMICRON (XBB.1.5)
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K982P AND V983P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (OMICRON SUB-LINEAGE XBB.1.5; BASED UPON GISAID:EPI_ISL_17157779), FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
RAXTOZINAMERAN [INN]
RAXTOZINAMERAN [WHO-DD]
RBP-020.2 4 (XBB.1.5 VARIANT)
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED PRE-FUSION SPIKE GLYCOPROTEIN OMICRON XBB.1.5 VARIANT (982-PROLINE,983-PROLINE)-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGERRBP020.2 4), INNER SALT

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAXTOZINAMERAN

Synonyms and Mappings

Resources